title: Subtype-specific suppression of Shiga toxin 2 released from Escherichia coli upon exposure to protein synthesis inhibitors.
abstract: Shiga toxins (Stx) are important virulence factors in the pathogenesis of severe disease including hemolytic-uremic syndrome, caused by Stx-producing Escherichia coli (STEC). STEC strains increase the release of Stx in vitro following the addition of fluoroquinolones, whereas protein synthesis inhibitors previously have been reported to suppress the release of Stx. The amount of Stx released from wild-type STEC strains incubated with protein synthesis inhibitors was examined by a Vero cell cytotoxicity assay. The amounts released were compared to the Stx type (Stx1 or Stx2) and additionally to the individual subtypes and toxin variants of Stx2. In general, Stx2 release was suppressed significantly upon exposure to protein synthesis inhibitors at MICs, which was not observed in the case of Stx1. Also, the average amount of different Stx2 toxin variants released was suppressed to various levels ranging from 14.0% (Stx2-O157-EDL933) to 94.7% (Stx2d-O8-C466-01B). Clinical studies exploring protein synthesis inhibitors as future candidates for treatment of intestinal infections caused by Stx2-producing STEC should therefore include knowledge of the toxin variant in addition to the subtype.
authors.affiliation: Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Copenhagen, Denmark.
authors.forename: Malene Gantzhorn
authors.initials: MG
authors.lastname: Pedersen
authors.forename: Claus
authors.initials: C
authors.lastname: Hansen
authors.forename: Erik
authors.initials: E
authors.lastname: Riise
authors.forename: Søren
authors.initials: S
authors.lastname: Persson
authors.forename: Katharina E P
authors.initials: KE
authors.lastname: Olsen
mesh_terms: D017963:Azithromycin / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology; D054324:Enterohemorrhagic Escherichia coli / Q000187:drug effects*; D019453:Escherichia coli O157 / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology; D048628:Ketolides / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*; D022641:Shiga Toxin 2 / Q000037:antagonists & inhibitors / Q000096:biosynthesis*
chemical_list: D005839:Gentamicins; D048628:Ketolides; D011500:Protein Synthesis Inhibitors; D022641:Shiga Toxin 2; D002939:Ciprofloxacin; D017963:Azithromycin; C106791:telithromycin